Aimei Health Technology Co., Ltd (AFJK) Revenue History
Annual and quarterly revenue from 2023 to present
AFJK Revenue Over Time (2023–2025)
AFJK Revenue Growth History
- FY2023 revenue growth
- N/A
- FY2024 revenue growth
- N/A
- FY2025 revenue growth
- N/A
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $0 | — |
| Q4 2025 | $0 | — |
| Q3 2025 | $0 | — |
| Q2 2025 | $0 | — |
| Q1 2025 | $0 | — |
| Q4 2024 | $0 | — |
| Q3 2024 | $0 | — |
| Q2 2024 | $0 | — |
AFJK Revenue Analysis (2023–2025)
Current Revenue & Growth
As of June 23, 2026, Aimei Health Technology Co., Ltd (AFJK) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q1 2026) recorded $0 in revenue
Historical Growth Trajectory
AFJK's historical revenue data shows various trends over time.
Peer Comparison
Compared to Financial Services sector peers — including CANG (+232.3% YoY), BTBT, and CLOV (+48.4% YoY). Compare AFJK vs CANG →
AFJK Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| AFJKCurrent | $0 | - | - | - | |
 CANG | $4.8B | +232.3% | +18.6% | -14.4% | |
 BTBT | $114M | - | - | -49.8% | |
 CLOV | $1.9B | +48.4% | +23.4% | -4.4% | |
 ACMR | $901M | +19.7% | +41.9% | 12.1% | |
 GDRX | $797M | -1.2% | +7.7% | 11.0% |
AFJK Historical Revenue Data (2023–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $0 | - | $-835,759 | - |
| 2024 | $0 | - | $0 | - | $-1,065,000 | - |
| 2023 | $0 | - | $0 | - | $-28,459 | - |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
3+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
AFJK — Frequently Asked Questions
Quick answers to the most common questions about buying AFJK stock.
Is AFJK's revenue growth accelerating or slowing?
AFJK TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is AFJK's revenue history from 2023 to 2026?
Aimei Health Technology Co., Ltd (AFJK) revenue history spans 2023 to 2026. TTM revenue as of 2026 is $0.00, growing at N/A YoY. The 5-year CAGR is N/A. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is AFJK's long-term revenue growth rate (CAGR)?
Aimei Health Technology Co., Ltd's 5-year revenue CAGR of N/A reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of N/A is in line with this long-term average. CAGR is the most reliable measure of sustained revenue momentum for AFJK.
Why does AFJK's quarterly revenue fluctuate?
AFJK quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. Aimei Health Technology Co., Ltd's revenue data from 2023 to 2026 shows full historical quarterly detail on this page.
How is AFJK's revenue distributed by segment?
AFJK reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does AFJK's revenue compare to industry peers?
Aimei Health Technology Co., Ltd (AFJK) with TTM revenue of $0.00 and N/A YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.